Infectious uveitis is a sight-threatening inflammatory condition affecting the uvea, the middle layer of the eye, and is caused by various infectious agents. Bacterial, viral, fungal, and parasitic infections can lead to uveitis, triggering inflammation and potentially causing long-term damage to ocular structures. Common pathogens associated with infectious uveitis include herpes simplex virus, cytomegalovirus, toxoplasma, tuberculosis, and syphilis. These infections can manifest with symptoms such as eye pain, redness, blurred vision, and sensitivity to light. Diagnosis involves a thorough examination, including laboratory tests, imaging studies, and sometimes ocular fluid analysis to identify the causative agent. Prompt and targeted treatment with antimicrobial agents is essential to control the infection and prevent complications. Complications of infectious uveitis may include glaucoma, cataracts, and retinal damage. Chronic inflammation can lead to vision impairment or even blindness if left untreated. Management requires a multidisciplinary approach involving ophthalmologists and infectious disease specialists, and follow-up care is crucial for monitoring and preventing recurrence. Early detection, accurate diagnosis, and timely intervention are critical in preserving visual function and improving outcomes for individuals with infectious uveitis.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States